BSECompany Update6 Oct 2026 · 6 Oct 2026, 10:20 am

PFA

Biogen Pharmachem Industries Ltd · 531752

✦ AI Summary

Biogen Pharmachem Industries Ltd submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, confirming the dematerialization of securities and cancellation of physical certificates.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Biogen Pharmachem Industries Ltd - 531752 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

0986daf4-cae1-47e1-a46c-6fbc4a5fc2e4.pdf

pdf

Download →
View document text
BIOGEN PHARMACHEM INDUSTRIES LIMITED CIN NO: L51100GJ1995PLC026702 (Formerly Known as SUN TECHNO OVERSEAS LIMITED) Date: 06.10.2026 Listing Department, BSE Limited, P J Tower, Dalal Street, Mumbai-400001 Scrip Code: 531752 Security ID: BIOGEN SUB: Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th September 2026. Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from Satellite Corporate Services Private Limited, Registrar & Share Transfer Agent of the Company for the quarter ended on 30th September 2026. This is for your information and records. Thanking You. FOR, BIOGEN PHARMACHEM INDUSTRIES LIMITED KELASH BUNKAR DIRECTOR Copy To: 1. National Securities Depository Ltd., Trade World, A wing, 4th Floor, Kamala Mills Compound, Lower Parel, Mumbai – 400013 2. Central Depository Services (India) Ltd, Marathon Futurex, A-Wing, 25th floor, NM Joshi Marg, Lower Parel, Mumbai 400013 Registered Office Address: Shop No. 8, First Floor, Makers – 1 Building, Jawahar Road, Rajkot-360001 E mail biogenpharmachem@gmail.com Date: 05.10.2026 BIOGEN PHARMACHEM INDUSTRIES LIMITED SHOP NO. 8, FIRST FLOOR, MAKERS ‐ 1 BUILDING, JAWAHAR ROAD RAJKOT GUJARAT‐360001 Subject: Certificate under Regulation 74(5) of the SEBI (Depository and participants) Regulations, 2018 for the quarter ended 30th September 2026. Dear Sir/Madam, In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026., w.r.t. physical shares certificates received for dematerialization of securities (Equity Shares) of the Company, “Biogen Pharmachem Industries Limited”. We hereby confirm and certify the following: a) The securities comprised in the said certificate(s) have been listed on the Stock Exchanges. b) The said certificate(s) after due verification have been mutilated and cancelled and the name of depository has been substituted in our records as registered owner. However in case of Biogen Pharmachem Industries Limited no physical certificates are received for demat during the quarter ended 30th September 2026. This is for you information and records. Thanking you, For Satellite Corporate Services Pvt. Ltd. Michael Monteiro (Director)